Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BocaGreenMD is a specialty pharmaceutical company focused on the development and commercialization of women's health products, with a primary emphasis on prenatal nutrition. The company is best known for its Prena1 line of prescription prenatal vitamins, including Prena1 Pearl and Prena1 Chew, which are designed to provide comprehensive nutritional support for expectant mothers. Originally operating as a subsidiary or brand within the Boca Pharma group, BocaGreenMD was acquired by Avadel Pharmaceuticals in 2017. In 2019, the product portfolio was subsequently sold to Apotex as part of a strategic divestiture. The company's mission was to provide high-quality, cost-effective therapeutic options for women's wellness and obstetric care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BOCAGREENMD.